Chief Executive Officer & Chairman, Bristol-Myers Squibb Company
Most recently reported pay: $5.8M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock
Oct 26, 2026https://www.marketbeat.com/articles/bristol-myers-squibbs-cancer-breakthrough-could-have-implications-beyond-its-own-stock/sentiment +0.40
Izalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cancer Compared to Chemotherapy in the Phase 3 PANKU-Lung01 Study
Oct 26, 2026https://www.businesswire.com/news/home/20261022265969/en/Izalontamab-Brengitecan-Iza-Bren-Doubles-Median-Progression-Free-Survival-in-Patients-with-Previously-Treated-EGFR-Mutated-Non-Small-Cell-Lung-Cancer-Compared-to-Chemotherapy-in-the-Phase-3-PANKU-Lung01-Study/sentiment +0.80
Should You Buy Bristol Myers Squibb While It Trades Below 10 Times Forward Earnings?
Oct 25, 2026https://www.fool.com/investing/2026/10/25/should-you-buy-bristol-myers-squibb-while-it-trade/sentiment +0.60
Biotech stocks are surging. How investors can play the new drug innovation boom
Oct 24, 2026https://www.cnbc.com/2026/10/24/biotech-stocks-drug-innovation-rally.htmlsentiment +0.30
Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know
Oct 16, 2026https://247wallst.com/investing/2026/10/16/bristol-myers-squibbs-4-2-dividend-yield-comes-with-a-trade-off-investors-should-know/sentiment +0.20
BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock?
Oct 12, 2026https://www.zacks.com/stock/news/3005229/bmy-surges-35-7-in-a-year-should-you-buy-sell-or-hold-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-3005229sentiment +0.80
